Somnigroup International Inc. short interest in 2025
In 2025, Somnigroup International Inc.'s disclosed short interest ran from 3.30% of shares outstanding on 15 Jan 2025 to 2.60% on 31 Dec 2025, a change of -0.70 percentage points. The year's high was 12.26% on 30 Apr 2025 and its low 2.27% on 15 Dec 2025, averaging 5.24% across 19 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 8.94 days on 13 Jun 2025. Full history: Somnigroup International Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 3.30% (15 Jan 2025)
- End of year
- 2.60% (31 Dec 2025)
- Change
- -0.70 pp
- High
- 12.26% (30 Apr 2025)
- Low
- 2.27% (15 Dec 2025)
- Average
- 5.24%
- Highest days to cover
- 8.94 (13 Jun 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 3.30% | 5.17 | |
| 31 Jan 2025 | 3.02% | 2.57 | |
| 30 Apr 2025 | 12.26% | 8.93 | results (8-K), 10-K filed |
| 15 May 2025 | 8.89% | 4.07 | results (8-K), 10-Q filed |
| 30 May 2025 | 8.45% | 7.29 | |
| 13 Jun 2025 | 9.11% | 8.94 | |
| 30 Jun 2025 | 7.76% | 6.89 | |
| 15 Jul 2025 | 6.02% | 4.75 | |
| 31 Jul 2025 | 5.19% | 5.05 | |
| 15 Aug 2025 | 4.75% | 3.15 | results (8-K), 10-Q filed |
| 29 Aug 2025 | 4.50% | 4.15 | |
| 15 Sep 2025 | 3.98% | 4.47 | |
| 30 Sep 2025 | 3.73% | 3.93 | |
| 15 Oct 2025 | 3.92% | 5.15 | |
| 31 Oct 2025 | 3.38% | 4.41 | |
| 14 Nov 2025 | 3.14% | 2.42 | results (8-K), 10-Q filed |
| 28 Nov 2025 | 3.23% | 2.97 | |
| 15 Dec 2025 | 2.27% | 3.15 | |
| 31 Dec 2025 | 2.60% | 3.86 |
See also: Somnigroup International Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.